^
Association details:
Biomarker:No biomarker
Cancer:Neuroendocrine Tumor
Regimen:FAS (5-fluorouracil + doxorubicin hydrochloride + Zanosar (streptozocin))
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Pancreatic Neuroendocrine Tumors (Well-Differentiated Grade 1/2): Other Recommended Regimens...Cytotoxic chemotherapy options considered in patients with bulky, symptomatic, and/or progressive disease include: 5-FU + doxorubicin + streptozocin (FAS).